21 November

SBIR/STTR

The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs encourage domestic small businesses to engage in Federal Research/Research and Development (R/R&D) that has the potential for commercialization.

21 November

NCI ALMANAC

Helps researchers identify potentially promising combinations of cancer drugs by providing data and analysis tools showing how well pairs of FDA-approved cancer drugs performed in killing tumor cells from the NCI-60 Human Tumor Cell Lines.

21 November

NCATS SMART IRB Platform

Through its Clinical and Translational Science Awards (CTSA) Program, NCATS is developing a single institutional review board (IRB) platform for multisite clinical studies: the NCATS Streamlined, Multisite, Accelerated Resources for Trials (SMART) IRB Platform. The goal is to provide flexible …

21 November

NCI Formulary

The NCI Formulary is particularly useful to investigators who would like to perform combination studies that focus on agents targeting molecular pathways from multiple collaborating pharmaceutical companies. A goal of the NCI Formulary is to improve the clinical trial implementation …

21 November

Research Match

ResearchMatch is a free, secure registry, making it easier for the public to volunteer and to become involved in clinical research studies that contribute to improved human health. The tool is expected to reduce recruitment costs, increase enrollment and speed …

21 November

PhenX Toolkit

Offers well-established, broadly validated measures of phenotypic traits and environmental exposures of interest to investigators in human genomics, epidemiology and biomedical research.

21 November

Assay Guidance Manual

The Assay Guidance Manual initiative delivers resources on best practices within the early stages of development as well as training focusing on robust, early-stage drug discovery assays.